help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muller, O. A.
Right arrow Articles by von Werder, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muller, O. A.
Right arrow Articles by von Werder, K.

Journal of Clinical Endocrinology & Metabolism, Vol 57, 227-229, Copyright © 1983 by Endocrine Society


ARTICLES

Corticotropin releasing factor: a new tool for the differential diagnosis of Cushing's syndrome

OA Muller, GK Stalla and K von Werder

One-hundred micrograms corticotropin-releasing factor (CRF) was administered as an i.v. bolus to 6 women and one man patient with pituitary ACTH dependent Cushing's disease, one patient with ectopic ACTH secretion from a lung oat cell carcinoma, and 2 patients with hypercortisolism due to an unilateral adrenal adenoma and adrenal carcinoma. Though 4 out of 7 patients with pituitary ACTH-dependent Cushing's disease had normal basal ACTH levels, all 7 patients showed hyperresponsiveness of ACTH secretion after CRF administration compared to normal controls. Cortisol levels showed a similar pattern, with a significantly higher cortisol increase compared to normal controls. In contrast ACTH hypersecretion of ectopic origin could not be stimulated further by CRF administration, ACTH and cortisol remaining unchanged over the test period of 120 minutes. Suppressed ACTH levels below 5 pg/ml in the 2 patients with hypercortisolism of adrenal origin remained suppressed and cortisol levels did not change after CRF. We conclude that CRF administration is an effective tool in the differential diagnosis of Cushing's syndrome.


This article has been cited by other articles:


Home page
EndocrinologyHome page
V. Castillo, D. Giacomini, M. Paez-Pereda, J. Stalla, M. Labeur, M. Theodoropoulou, F. Holsboer, A. B. Grossman, G. K. Stalla, and E. Arzt
Retinoic Acid as a Novel Medical Therapy for Cushing's Disease in Dogs
Endocrinology, September 1, 2006; 147(9): 4438 - 4444.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. M. Isidori, G. A. Kaltsas, S. Mohammed, D. G. Morris, P. Jenkins, S. L. Chew, J. P. Monson, G. M. Besser, and A. B. Grossman
Discriminatory Value of the Low-Dose Dexamethasone Suppression Test in Establishing the Diagnosis and Differential Diagnosis of Cushing's Syndrome
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5299 - 5306.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Newell-Price, D. G. Morris, W. M. Drake, M. Korbonits, J. P. Monson, G. M. Besser, and A. B. Grossman
Optimal Response Criteria for the Human CRH Test in the Differential Diagnosis of ACTH-Dependent Cushing's Syndrome
J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1640 - 1645.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. I. Wiggam, A. P. Heaney, E. M. McIlrath, D. R. McCance, B. Sheridan, D. R. Hadden, and A. B. Atkinson
Bilateral Inferior Petrosal Sinus Sampling in the Differential Diagnosis of Adrenocorticotropin-Dependent Cushing's Syndrome: A Comparison with Other Diagnostic Tests
J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1525 - 1532.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Sakai, N. Horiba, K. Sakai, F. Tozawa, A. Kuwayama, H. Demura, and T. Suda
Corticotropin-Releasing Factor Up-Regulates Its Own Receptor Gene Expression in Corticotropic Adenoma Cells in Vitro
J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1229 - 1234.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1983 by The Endocrine Society